Carisma Therapeutics, Inc.CARMNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR-23.9%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
-23.9%/yr
Annual compound
Percentile
P69
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202443.63%
2023-70.39%
2022-4030.43%
202199.03%
202083.88%
2019-116.68%
201850.94%
2017-1342.46%
2016105.08%
201525.30%